Size of this preview: 800 × 396 pixels. Other resolutions: 320 × 158 pixels | 640 × 317 pixels | 1,024 × 507 pixels | 1,280 × 633 pixels | 2,882 × 1,426 pixels.
Original file (2,882 × 1,426 pixels, file size: 427 KB, MIME type: image/png)
Summary
| Description |
English: Nalfurafine (INN, USAN) (brand name Remitch; former developmental code names TRK-820, AC-820, MT-9938) is an antipruritic (anti-itch drug) that is marketed in Japan for the treatment of uremic pruritus in individuals with chronic kidney disease undergoing hemodialysis. It acts as a potent, selective, centrally-penetrant κ-opioid receptor (KOR) agonist, and is the first and currently the only selective KOR agonist to have been approved for clinical use. It has also been dubiously referred to as the "first non-narcotic opioid drug" in history. |
| Date | |
| Source | Own work |
| Author | Mplanine |
Licensing
I, the copyright holder of this work, hereby publish it under the following license:
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 17:20, 12 November 2022 | | 2,882 × 1,426 (427 KB) | Mplanine | Uploaded own work with UploadWizard |
File usage
The following pages on the English Wikipedia use this file (pages on other projects are not listed):
